Global Ceftiofur Market - 2022-2029

Global Ceftiofur Market - 2022-2029
Market Overview

Ceftiofur Market size was valued US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

Ceftiofur is a veterinary drug that has been licensed to treat a variety of ailments in pigs, beef or dairy cattle, and other animals. It is a third-generation cephalosporin antibiotic that inhibits bacterial growth by attaching to and inactivating penicillin-binding proteins (PBPs) on bacterial cell walls.

Market Dynamics

High adoption of Ceftiofur drug for swine influenza virus is expected to drive market growth.

The swine influenza virus is widespread in pig populations all over the world. It is uncommon for the virus to spread from pigs to humans; in many cases, it causes the blood to produce antibodies rather than the flu. It is known as zoonotic swine flu if transmission results in human influenza. Those who frequently contact pigs are more likely to contract the swine flu. For instance, G4 EA H1N1, sometimes referred to as the G4 swine flu virus (G4), is a strain of the swine influenza virus found in China in 2020. The virus is a Eurasian avian-like (EA) variant genotype 4 (G4) H1N1 virus that primarily infects pigs, while there is some indication that it can also infect humans.

Moreover, On November 5, 2021, the Centers for Disease Control and Prevention (CDC) in the United States announced that the influenza season of 2020–2021 saw three human infections with new influenza A viruses. However, there was no evidence of any human-to-human transmission among these swine flu' cases. Therefore, it has increased the demand for the Ceftiofur drug. Thus, from the above statements, the market is expected to drive in the forecast period.

Restraint

The high cost associated with the medication and treatment approaches and adverse effects of these antibiotics is the factors the market is expected to hamper the market growth in the forecast period. For instance, Injections into the IM can be uncomfortable, and local phlebitis may develop after numerous IV administrations. Vomiting, diarrhea, and nausea are possible side effects. Numerous types of hypersensitivity reactions have been observed, especially in animals who previously had an acute penicillin allergy.

Industry Analysis

The ceftiofur market provides in-depth analysis of the market based on various industry factors such as supply chain analysis, pricing analysis etc.

COVID-19 Impact Analysis

The COVID-19 pandemic has moderately impacted the market. During the pandemic, there was an increase in reproductive tract infections and skin & soft tissue infections among swine and cattle worldwide. Therefore, the pandemic has resulted in the increased consumption of antibiotic medicines. In contrast, the pandemic interrupts the supply chain and process. Many companies will vary to other geographic regions to ensure that products remain available and protect their supply chain. Thus, from the above statements, the market got affected, and it is expected to gain traction quickly with the resumption of economic activities.

Segment Analysis

Ceftiofur Hydrochloride segment is expected to hold the largest market share in ceftiofur market

The ceftiofur hydrochloride segment is expected to dominate in 2021. Ceftiofur Hydrochloride is the hydrochloride salt version of ceftiofur, a third-generation cephalosporin that is semi-synthetic, beta-lactamase-stable, broad-spectrum, and antibacterial. Penicillin-binding proteins (PBPs) on the bacterial cell wall's inner membrane are attracted to and inactive by ceftiofur. PBPs are enzymes that modify the bacterial cell wall during growth and division and the final stages of cell wall synthesis. PBP inactivation hinders the cross-linking of peptidoglycan chains, which is essential for the strength and stiffness of bacterial cell walls. This weakens the bacterial cell wall and leads to cell lysis in the bacteria.

Moreover, Ceftiofur hydrochloride is also used to treat and manage infections brought on by susceptible microorganisms in cattle and pigs. It is approved to treat Mannheimia, P. multocida, and H. somni-related respiratory diseases in cattle. For instance, EXCENEL RTU EZ Sterile Suspension is a ready-to-use formulation containing the hydrochloride salt of ceftiofur, a broad spectrum cephalosporin antibiotic. It is indicated for treatment/ control of swine bacterial respiratory disease (swine bacterial pneumonia) associated with Actinobacillus pleuropneumoniae, Pasteurella multocida, Salmonella Choleraesuis and Streptococcus suis, and Cattle(Bovine respiratory disease, Acute bovine interdigital necrobacillosis, Acute metritis). Thus, from the above statements, the market is expected to hold the largest market share in the forecast period.

Geographical Analysis

North America region holds the largest market share in the global ceftiofur market

In 2021, North America accounted for the highest revenue share. The increasing prevalence of Swine Influenza, increased rates of fatal drug overdoses, well-established infrastructure, and huge R&D investments by key market players in the region are some factors the market is expected to boost in the forecast period. For instance, In the United States, xylazine, an animal tranquilizer, is more frequently connected to fatal drug overdoses. In 25 of the 38 states looked at for this new analysis, the Centers for Disease Control and Prevention, xylazine has been found in overdose deaths. In 64 percent of cases involving xylazine deaths in 2019, fentanyl was almost invariably present. Opioids like fentanyl or heroin are mixed with the medication to increase their effects. But this mixture has the potential to make sedation and respiratory depression worse. This increases the chance of a fatal overdose. Therefore, it has increased the demand for quick and efficient remedies. Thus, from the above statements, the North American region is expected to hold the largest market share in the forecast period.

Competitive Landscape

Major key players in the ceftiofur market are Zoetis Services LLC , Hipra, Merck & Co., Inc., Ceva Sante Animale, AdvaCare Pharma, Norbrook, Cephazone Pharma LLC, Orchid Chemicals & Pharmaceuticals Ltd, QILU SYNVA CO.,LTD.

Zoetis Services LLC:

Overview:

Zoetis is a global animal health company focusing on livestock and companion animals. It is involved in the discovery, development, production, and marketing of animal health drugs, vaccines, and diagnostic tools. Biodevices, genetic diagnostics, and precision livestock farming supplement its goods. The business, among other things, sells vaccines, parasiticides, anti-infective treatments, and medicated feed additives. Through its client supply services (CSS) organization, it also provides contract manufacturing services to other parties. The company has manufacturing sites worldwide, and it sells goods through direct marketing channels and distributors in the Americas, Europe, Africa, Asia, and Australia to veterinarians, livestock producers, and people who raise and care for farm and companion animals.

Product Portfolio:

SPECTRAMAST DC (ceftiofur hydrochloride): SPECTRAMAST DC (ceftiofur hydrochloride) Sterile Suspension provides a broad-spectrum label to treat the most common bacterial pathogens found in dry cows on modern dairies, including: Staphylococcus aureus, Streptococcus dysgalactiae and Streptococcus uberis.

The global ceftiofur market report would provide an access to an approx. 45+market data table, 40+figures and 200pages.